Mark Donovan
Impact in
-
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
- Blood Pressure and Hypertension Studies
-
- Diabetes Treatment and Management
- Diabetes Management and Research
Papers in
-
- Diabetes Treatment and Management 9
- Diabetes Management and Research 4
- Hormonal Regulation and Hypertension 2
-
- Metabolism, Diabetes, and Cancer 6
- Protein Degradation and Inhibitors 2
- Co-authors
- Barry M. Massie (4 shared papers)Michael R. Zile (4 shared papers)Agata Ptaszynska (5 shared papers)John J.V. McMurray (4 shared papers)Robert S. McKelvie (3 shared papers)Michel Komajda (3 shared papers)Peter E. Carson (4 shared papers)Susan Anderson (1 shared paper)
- Journals
- Clinical Cancer Research (1 paper)Pharmaceutical Statistics (1 paper)Journal of Cardiac Failure (1 paper)Diabetes/Metabolism Research and Reviews (1 paper)Circulation (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Mark Donovan
18 papers receiving 2.0k citations
Mark Donovan's Hit Papers
Peers
Comparison fields: 5 of 77
- Cardiology and Cardiovascular Medicine 1.4k
- Endocrinology, Diabetes and Metabolism 722
- Complementary and alternative medicine 79
- Oncology 218
- Family Practice 16
Countries citing papers authored by Mark Donovan
This map shows the geographic impact of Mark Donovan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Donovan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Donovan more than expected).
Fields of papers citing papers by Mark Donovan
This network shows the impact of papers produced by Mark Donovan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Donovan. The network helps show where Mark Donovan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Donovan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction Hit paper breakdown → | 2008 | 1362 |
| 2 | 2010 | 182 | |
| 3 | 2012 | 146 | |
| 4 | 2018 | 54 | |
| 5 | 2014 | 53 | |
| 6 | 2009 | 49 | |
| 7 | 2013 | 46 | |
| 8 | 2013 | 43 | |
| 9 | 2009 | 25 | |
| 10 | 2023 | 23 | |
| 11 | 2018 | 15 | |
| 12 | 2011 | 14 | |
| 13 | 2008 | 14 | |
| 14 | 2007 | 13 | |
| 15 | 2004 | 9 | |
| 16 | Abstract 978: Cardiovascular Safety of Saxagliptin as Mono- or Add-on Therapy in Patients With Type 2 Diabetes | 2009 | 2 |
| 17 | Saxagliptin clinical trials: evaluation of CV risk | 2010 | 2 |
| 18 | 2008 | 1 | |
| 19 | 2017 | 0 | |
| 20 | 2010 | 0 |
About Mark Donovan
Mark Donovan is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 2.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (9 papers), Metabolism, Diabetes, and Cancer (6 papers), Diabetes Management and Research (4 papers), Heart Failure Treatment and Management (4 papers), Cardiovascular Function and Risk Factors (4 papers), Cardiac pacing and defibrillation studies (3 papers), Protein Degradation and Inhibitors (2 papers) and Hormonal Regulation and Hypertension (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.4k citations), Endocrinology, Diabetes and Metabolism (722 citations), Complementary and alternative medicine (79 citations), Oncology (218 citations) and Family Practice (16 citations). Mark Donovan has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Barry M. Massie, Michael R. Zile, Agata Ptaszynska, John J.V. McMurray, Robert S. McKelvie, Michel Komajda, Peter E. Carson, Susan Anderson, C Staiger and Erik Iverson. Their work appears in journals such as Clinical Cancer Research, Pharmaceutical Statistics, Journal of Cardiac Failure, Diabetes/Metabolism Research and Reviews and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.